ev3 Inc. to Report 2009 Third Quarter Results and Host Conference Call on October 27, 2009
Oct 20, 2009
The company will host a conference call and webcast the same day at
The conference call will be available to interested parties through a live audio webcast at http://ir.ev3.net, where it will be archived and accessible for approximately 12 months. The live dial-in number for the call is 888-680-0878 (U.S.) or 617-213-4855 (International). The participant passcode is 66747346.
If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial 888-286-8010 (U.S.) or 617-801-6888 (International) and enter passcode 11076648. The audio replay will be available beginning at
About
Since its founding in 2000, ev3 has been dedicated to developing breakthrough and clinically proven technologies for the endovascular treatment of peripheral vascular and neurovascular diseases. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, flow diversion devices, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at www.ev3.net.
ev3 and the ev3 logo are trademarks of
CONTACT
Investors and Media
(949) 680-1375
jtracy@ev3.net